Cargando…

Mast cells and eosinophils in invasive breast carcinoma

BACKGROUND: Inflammatory cells in the tumour stroma has gained increasing interest recently. Thus, we aimed to study the frequency and prognostic impact of stromal mast cells and tumour infiltrating eosinophils in invasive breast carcinomas. METHODS: Tissue microarrays containing 234 cases of invasi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amini, Rose-Marie, Aaltonen, Kirsimari, Nevanlinna, Heli, Carvalho, Ricardo, Salonen, Laura, Heikkilä, Päivi, Blomqvist, Carl
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central\|1 2007
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2048965/ https://www.ncbi.nlm.nih.gov/pubmed/17727696 http://dx.doi.org/10.1186/1471-2407-7-165

Ejemplares similares

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2005)

Relationship of patients' age to histopathological features of breast tumours in BRCA1 and BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2005)

Effect of image compression and scaling on automated scoring of immunohistochemical stainings and segmentation of tumor epithelium
por: Konsti, Juho, et al.
Publicado: (2012)

Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides
por: Aaltonen, K, et al.
Publicado: (2006)

Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk
por: Onay, Ummiye V, et al.
Publicado: (2008)

Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families
por: Eerola, Hannaleena, et al.
Publicado: (2008)

High cyclin B1 expression is associated with poor survival in breast cancer
por: Aaltonen, K, et al.
Publicado: (2009)

Variants on the promoter region of PTEN affect breast cancer progression and patient survival
por: Heikkinen, Tuomas, et al.
Publicado: (2011)

Breast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implications
por: Muranen, Taru A, et al.
Publicado: (2011)

Familial Breast Cancer in Southern Finland
por: Eerola, Hannaleena, et al.
Publicado: (1999)

MiR-34a Expression Has an Effect for Lower Risk of Metastasis and Associates with Expression Patterns Predicting Clinical Outcome in Breast Cancer
por: Peurala, Hanna, et al.
Publicado: (2011)

Comprehensive analysis of NuMA variation in breast cancer
por: Kilpivaara, Outi, et al.
Publicado: (2008)

BACH1 Ser919Pro variant and breast cancer risk
por: Vahteristo, Pia, et al.
Publicado: (2006)

SNPs in lncRNA Regions and Breast Cancer Risk
por: Suvanto, Maija, et al.
Publicado: (2020)

Pathogenic Variant Spectrum in Breast Cancer Risk Genes in Finnish Patients
por: Nurmi, Anna K., et al.
Publicado: (2022)

CHEK2 c.1100delC mutation is associated with an increased risk for male breast cancer in Finnish patient population
por: Hallamies, Sanna, et al.
Publicado: (2017)

A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ
por: Zhou, Wenjing, et al.
Publicado: (2013)

High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome
por: Jamshidi, Maral, et al.
Publicado: (2021)

RAD51, XRCC3, and XRCC2 mutation screening in Finnish breast cancer families
por: Pelttari, Liisa M, et al.
Publicado: (2015)

Markers associated with genomic instability, immunogenicity and immune therapy responsiveness in Metaplastic carcinoma of the breast: Expression of γH2AX, pRPA2, P53, PD-L1 and tumor infiltrating lymphocytes in 76 cases
por: Voutilainen, S., et al.
Publicado: (2022)

Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study
por: Zhou, Wenjing, et al.
Publicado: (2010)

Meta-analysis of three genome-wide association studies identifies two loci that predict survival and treatment outcome in breast cancer
por: Khan, Sofia, et al.
Publicado: (2017)

Eosinophil peroxidase-induced mast cell secretion
Publicado: (1980)

Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
por: Zhou, Wenjing, et al.
Publicado: (2013)

NTHL1 is a recessive cancer susceptibility gene
por: Nurmi, Anna K., et al.
Publicado: (2023)

The prognostic role of HER2 expression in ductal breast carcinoma in situ (DCIS); a population-based cohort study
por: Borgquist, Signe, et al.
Publicado: (2015)

ATM variants and cancer risk in breast cancer patients from Southern Finland
por: Tommiska, Johanna, et al.
Publicado: (2006)

Asthma: Eosinophil Disease, Mast Cell Disease, or Both?
por: Bradding, Peter
Publicado: (2008)

Glycomic analysis of human mast cells, eosinophils and basophils
por: North, Simon J, et al.
Publicado: (2012)

Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas
por: Karihtala, Peeter, et al.
Publicado: (2022)

Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families
por: Muranen, Taru A., et al.
Publicado: (2016)

Biomarkers of the involvement of mast cells, basophils and eosinophils in asthma and allergic diseases
por: Metcalfe, Dean D., et al.
Publicado: (2016)

Activation of Eosinophils and Mast Cells in Functional Dyspepsia: an Ultrastructural Evaluation
por: Vanheel, Hanne, et al.
Publicado: (2018)

Bidirectional Mast Cell–Eosinophil Interactions in Inflammatory Disorders and Cancer
por: Galdiero, Maria Rosaria, et al.
Publicado: (2017)

Strong association of mast cells with eosinophilic esophagitis‐specific signatures
por: Alvarado, Diego, et al.
Publicado: (2022)

The relationship between histologic grades of invasive carcinoma of breast ducts and mast cell infiltration
por: Fakhrjou, Ashraf, et al.
Publicado: (2016)

Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients
por: Nurmi, Anna, et al.
Publicado: (2019)

Tenascin-C expression in invasion border of early breast cancer: a predictor of local and distant recurrence.
por: Jahkola, T., et al.
Publicado: (1998)

Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients
por: Pelttari, Liisa M, et al.
Publicado: (2012)

Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics
por: Jönsson, Göran, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_eaqv6klq34m0fkn7r19hrri4e0